Does CERTOLIZUMAB PEGOL Cause Lymphadenopathy? 272 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 272 reports of Lymphadenopathy have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 0.3% of all adverse event reports for CERTOLIZUMAB PEGOL.
272
Reports of Lymphadenopathy with CERTOLIZUMAB PEGOL
0.3%
of all CERTOLIZUMAB PEGOL reports
0
Deaths
46
Hospitalizations
How Dangerous Is Lymphadenopathy From CERTOLIZUMAB PEGOL?
Of the 272 reports, 46 (16.9%) required hospitalization, and 6 (2.2%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
Yes, Lymphadenopathy is listed as a known adverse reaction in the official FDA drug label for CERTOLIZUMAB PEGOL.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Lymphadenopathy Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX